The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context.
COPD
Italy
Tdap vaccine
pertussis
vaccination
whooping cough
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
14
8
2019
medline:
22
6
2021
entrez:
13
8
2019
Statut:
ppublish
Résumé
Despite high rates of vaccination, pertussis resurgence has been reported worldwide in recent years, including in Italy, especially in older adults.Chronic obstructive pulmonary disease (COPD) is a respiratory disease associated with progressive inflammation of the respiratory tract. Regional population studies have shown the prevalence of COPD in Italy to be approximately 15% with an age-dependent increase in proportion of COPD cases.Emerging data shows that individuals with COPD are at high risk of contracting pertussis. Furthermore, those who develop pertussis could experience exacerbation of their pre-existent COPD and further susceptibility to other infections.Immunization programs in Italy currently recommend a decennial reduced-antigen-content diphtheria-tetanus-acellular pertussis booster vaccine dose for adults. Active measures to encourage booster vaccination, especially for high-risk adults such as those with COPD, could positively impact pertussis morbidity and the associated healthcare burden.
Identifiants
pubmed: 31403385
doi: 10.1080/21645515.2019.1652517
pmc: PMC7062424
doi:
Substances chimiques
Diphtheria-Tetanus-acellular Pertussis Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
340-348Références
Clin Exp Vaccine Res. 2017 Jan;6(1):22-30
pubmed: 28168170
Trends Immunol. 2009 Jul;30(7):351-9
pubmed: 19540808
Ont Health Technol Assess Ser. 2012;12(3):1-64
pubmed: 23074431
Curr Opin Pulm Med. 2013 Mar;19(2):125-32
pubmed: 23361194
Vaccine. 2018 Nov 19;36(48):7270-7275
pubmed: 30337176
Int J Chron Obstruct Pulmon Dis. 2015 Jan 07;10:95-109
pubmed: 25609943
Ann Med. 2018 May;50(3):193-208
pubmed: 29308916
F1000 Biol Rep. 2013;5:3
pubmed: 23413371
Pathog Dis. 2013 Dec;69(3):194-204
pubmed: 23893966
Multidiscip Respir Med. 2014 May 19;9(1):25
pubmed: 25057359
J Prev Med Hyg. 2018 Jun 01;59(2):E128-E131
pubmed: 30083619
PLoS One. 2013 May 10;8(5):e62985
pubmed: 23675448
J Infect Dis. 2000 Jul;182(1):174-9
pubmed: 10882595
MMWR Recomm Rep. 2018 Apr 27;67(2):1-44
pubmed: 29702631
Eur Respir J. 2010 Jun;35(6):1209-15
pubmed: 20513910
Expert Rev Respir Med. 2015 Apr;9(2):153-9
pubmed: 25586213
Thorax. 2006 Mar;61(3):189-95
pubmed: 16227328
Vaccine. 2014 Feb 3;32(6):639-44
pubmed: 24370712
Am Rev Respir Dis. 1975 Jan;111(1):27-36
pubmed: 163065
J Glob Health. 2015 Dec;5(2):020415
pubmed: 26755942
J Med Microbiol. 2016 Jul;65(7):649-657
pubmed: 27075481
Tanaffos. 2015;14(3):172-6
pubmed: 26858762
Lancet. 2012 Apr 7;379(9823):1341-51
pubmed: 22314182
Vaccine. 1999 Jan 21;17(3):286-90
pubmed: 9987165
Respir Med. 2003 Mar;97 Suppl C:S43-50
pubmed: 12647942
Euro Surveill. 2014 Oct 09;19(40):20921
pubmed: 25323077
Infection. 2005 Feb;33(1):13-7
pubmed: 15750754
Comput Methods Programs Biomed. 2013 Aug;111(2):507-11
pubmed: 23769164
Clin Infect Dis. 2010 May 15;50(10):1339-45
pubmed: 20370464
Clin Infect Dis. 2019 Jul 2;69(2):218-226
pubmed: 30321305
J Infect. 2013 Sep;67(3):169-84
pubmed: 23707875
Eur J Intern Med. 2014 Jul;25(6):528-32
pubmed: 24814432
Vaccine. 2017 Jul 24;35(33):4057-4059
pubmed: 28651836
Epidemiol Infect. 2017 Jul;145(10):2109-2121
pubmed: 28462763
CMAJ. 2005 Feb 15;172(4):509-15
pubmed: 15710944
Clin Infect Dis. 2008 Aug 1;47(3):328-38
pubmed: 18558873
PLoS One. 2013 Dec 11;8(12):e82967
pubmed: 24349407
BMC Infect Dis. 2013 Mar 26;13:151
pubmed: 23530907
Clin Microbiol Rev. 2016 Jul;29(3):449-86
pubmed: 27029594